P-glycoprotein (P-gp, ABCB1) increases in many gemcitabine-resistant cell lines and pancreatic cancer samples, and molecular docking plus lab tests show it can bind and pump out gemcitabine. The gene discussed is ABCB1; the disease is pancreatic neoplasm.